Sphera Funds Management’s Vigil Neuroscience VIGL Stock Holding History

Sphera Funds Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,604,429	Closed	-$2.86M	–	133
2025 Q1	$2.86M	Buy	1,604,429 +102,000	+7%	+$229K	0.7%	49
2024 Q4	$2.55M	Sell	1,502,429 -145,175	-9%	-$429K	0.47%	70
2024 Q3	$5.6M	Sell	1,647,604 -44,562	-3%	-$165K	0.92%	42
2024 Q2	$6.77M	Sell	1,692,166 -38,248	-2%	-$131K	1.1%	35
2024 Q1	$5.9M	Buy	1,730,414 +1,195,294	+223%	+$3.73M	0.96%	44
2023 Q4	$1.81M	Buy	+535,120	New	+$2.75M	0.34%	75

Other funds holding VIGL

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return